Phil Reason, CEO of Instem PLC (AIM:INS), joined Proactive with details of the company's 2022 financial performance.
The company grew revenues by 28% and underlying earnings were up 32%. It also said it expected to benefit in 2023 from ‘industry consolidation’.
Recent success include increased recurring revenue and a renewed contract with the US government's National Toxicology Program.